Questions Are Raised About Vaccine Panel’s Reliability as Policy Review Gets Underway

The New York Times

Sep 17

Senator Bill Cassidy warned against any new restrictions, and insurers suggested they would still cover routine vaccinations even if a C.D.C. panel tried to limit them.

Read the article here

VaccinationFederal Initiatives

St. Paul Corner Drug (SPCD)

Questions Are Raised About Vaccine Panel’s Reliability as Policy Review Gets Underway

CVS’s Omnicare Files Bankruptcy After $949 Million Judgment

Op-Ed: Vaccine Policy Changes Are Undoing Pharmacy Access

St. Paul Corner Drug